New center will incorporate research on the study of aging in the Department of Biology, Picower Institute for Learning and Memory, and David H. Koch Institute for Integrative Cancer Research.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Cancer biologist and Koch Institute director recognized with MIT faculty’s top honor.
Optimal size and shape allow implantable devices to last longer in the body.
Device can measure the distribution of tiny particles as they flow through a microfluidic channel.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
MIT innovators take a close look at how basic science research leads to applications, new companies, jobs, and economic growth.
Stimulating both major branches of the immune system halts tumor growth more effectively.
Discovery could offer a new target for treatment of glioblastoma.
Graduate student Steven Keating takes a problem-solving approach to his brain cancer.
MIT study finds evidence that a new strain of H1N1 may carry dangerous mutations.
Self-healing gel can be injected into the body and act as a long-term drug depot.